315 related articles for article (PubMed ID: 30606176)
1. Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.
Eun K; Park MG; Jeong YW; Jeong YI; Hyun SH; Hwang WS; Kim SH; Kim H
BMC Biotechnol; 2019 Jan; 19(1):1. PubMed ID: 30606176
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
3. The combinational use of CRISPR/Cas9-based gene editing and targeted toxin technology enables efficient biallelic knockout of the α-1,3-galactosyltransferase gene in porcine embryonic fibroblasts.
Sato M; Miyoshi K; Nagao Y; Nishi Y; Ohtsuka M; Nakamura S; Sakurai T; Watanabe S
Xenotransplantation; 2014; 21(3):291-300. PubMed ID: 24919525
[TBL] [Abstract][Full Text] [Related]
4. pKAMA-ITACHI Vectors for Highly Efficient CRISPR/Cas9-Mediated Gene Knockout in Arabidopsis thaliana.
Tsutsui H; Higashiyama T
Plant Cell Physiol; 2017 Jan; 58(1):46-56. PubMed ID: 27856772
[TBL] [Abstract][Full Text] [Related]
5. The Combinational Use of CRISPR/Cas9 and Targeted Toxin Technology Enables Efficient Isolation of Bi-Allelic Knockout Non-Human Mammalian Clones.
Watanabe S; Sakurai T; Nakamura S; Miyoshi K; Sato M
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617297
[TBL] [Abstract][Full Text] [Related]
6. No off-target mutations in functional genome regions of a CRISPR/Cas9-generated monkey model of muscular dystrophy.
Wang S; Ren S; Bai R; Xiao P; Zhou Q; Zhou Y; Zhou Z; Niu Y; Ji W; Chen Y
J Biol Chem; 2018 Jul; 293(30):11654-11658. PubMed ID: 29941452
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
8. An improved strategy for CRISPR/Cas9 gene knockout and subsequent wildtype and mutant gene rescue.
Jin J; Xu Y; Huo L; Ma L; Scott AW; Pizzi MP; Li Y; Wang Y; Yao X; Song S; Ajani JA
PLoS One; 2020; 15(2):e0228910. PubMed ID: 32053639
[TBL] [Abstract][Full Text] [Related]
9. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
[TBL] [Abstract][Full Text] [Related]
10. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
11. LeishGEdit: A Method for Rapid Gene Knockout and Tagging Using CRISPR-Cas9.
Beneke T; Gluenz E
Methods Mol Biol; 2019; 1971():189-210. PubMed ID: 30980304
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells.
Kamali E; Rahbarizadeh F; Hojati Z; Frödin M
BMC Biotechnol; 2021 Jan; 21(1):9. PubMed ID: 33514392
[TBL] [Abstract][Full Text] [Related]
13. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency.
Jensen KT; Fløe L; Petersen TS; Huang J; Xu F; Bolund L; Luo Y; Lin L
FEBS Lett; 2017 Jul; 591(13):1892-1901. PubMed ID: 28580607
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
15. Establishment of knockout adult sea urchins by using a CRISPR-Cas9 system.
Liu D; Awazu A; Sakuma T; Yamamoto T; Sakamoto N
Dev Growth Differ; 2019 Aug; 61(6):378-388. PubMed ID: 31359433
[TBL] [Abstract][Full Text] [Related]
16. Generation of genome-edited dogs by somatic cell nuclear transfer.
Kim DE; Lee JH; Ji KB; Park KS; Kil TY; Koo O; Kim MK
BMC Biotechnol; 2022 Jul; 22(1):19. PubMed ID: 35831828
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-Directed Gene Editing for the Generation of Loss-of-Function Mutants in High-Throughput Zebrafish F
Shankaran SS; Dahlem TJ; Bisgrove BW; Yost HJ; Tristani-Firouzi M
Curr Protoc Mol Biol; 2017 Jul; 119():31.9.1-31.9.22. PubMed ID: 28678442
[TBL] [Abstract][Full Text] [Related]
18. Application and optimization of CRISPR-Cas9-mediated genome engineering in axolotl (Ambystoma mexicanum).
Fei JF; Lou WP; Knapp D; Murawala P; Gerber T; Taniguchi Y; Nowoshilow S; Khattak S; Tanaka EM
Nat Protoc; 2018 Dec; 13(12):2908-2943. PubMed ID: 30429597
[TBL] [Abstract][Full Text] [Related]
19. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
[TBL] [Abstract][Full Text] [Related]
20. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
